HER-2 B Cell Peptide Vaccine
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
- Status
- COMPLETED
- Phase
- N/A
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Status
- RECRUITING
- Phase
- PHASE3
HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
- Status
- COMPLETED
- Phase
- NA
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
- Status
- RECRUITING
- Phase
- PHASE2
Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
- Status
- RECRUITING
- Phase
- PHASE2